| Investor | Iroquois Capital Management, LLC |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Iroquois Capital Management, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13G/A | IVDA / Iveda Solutions, Inc. | 714,286 | 585,068 | ||||
| 2026-05-15 | 13G/A | WRAP / Wrap Technologies, Inc. | 4,425,830 | 2,843,615 | ||||
| 2026-05-15 | 13G/A | FABC / Fabric.AI, Inc. | 161,595 | 161,442 | ||||
| 2026-05-15 | 13G/A | WORX / SCWorx Corp. | 1,153,662 | 1,700,723 | ||||
| 2026-05-15 | 13G | AUUD / Auddia Inc. | 581,421 | |||||
| 2026-02-17 | 13G/A | WORX / SCWorx Corp. | 1,217,058 | 1,153,662 | ||||
| 2026-02-17 | 13G/A | FABC / Fabric.AI, Inc. | 147,838 | 161,595 | ||||
| 2026-02-17 | 13G/A | PTPI / Petros Pharmaceuticals, Inc. | 3,313,704 | 4,434,773 | ||||
| 2026-02-17 | 13G/A | CMND / Clearmind Medicine Inc. | 603,470 | 166,464 | ||||
| 2026-02-13 | 13G | IVDA / Iveda Solutions, Inc. | 714,286 | |||||
| 2026-02-11 | 13G | WRAP / Wrap Technologies, Inc. | 1,337,673 | 4,425,830 | ||||
| 2025-11-18 | 13G/A | CMND / Clearmind Medicine Inc. | 451,685 | 603,470 | ||||
| 2025-11-17 | 13G/A | FABC / Fabric.AI, Inc. | 150,496 | 147,838 | ||||
| 2025-11-14 | 13G/A | BCTX / BriaCell Therapeutics Corp. | 1,600,000 | 98,944 | ||||
| 2025-11-14 | 13G/A | FABC / Fabric.AI, Inc. | 507,899 | 150,496 | ||||
| 2025-11-14 | 13G/A | BNGO / Bionano Genomics, Inc. | 525,000 | 509,658 | ||||
| 2025-11-14 | 13G/A | WORX / SCWorx Corp. | 403,850 | 1,217,058 | ||||
| 2025-11-14 | 13G/A | KWE / DEFSEC Technologies Inc. | 100,000 | 70,419 | ||||
| 2025-11-14 | 13G/A | TWAV / TaoWeave, Inc. | 367,853 | 168,445 | ||||
| 2025-09-18 | 13G | BNGO / Bionano Genomics, Inc. | 525,000 | |||||
| 2025-08-15 | 13G/A | PTPI / Petros Pharmaceuticals, Inc. | 5,939,954 | 3,313,704 | ||||
| 2025-08-14 | 13G/A | XXII / 22nd Century Group, Inc. | 558,150 | |||||
| 2025-08-14 | 13G/A | PRSO / Peraso Inc. | 2,380,951 | 1,428,570 | ||||
| 2025-08-14 | 13G/A | FABC / Fabric.AI, Inc. | 507,899 | |||||
| 2025-08-14 | 13G/A | WORX / SCWorx Corp. | 226,191 | 403,850 | ||||
| 2025-07-28 | 13G | KWE / DEFSEC Technologies Inc. | 100,000 | |||||
| 2025-07-28 | 13G | BCTX / BriaCell Therapeutics Corp. | 1,600,000 | |||||
| 2025-06-17 | 13G | TWAV / TaoWeave, Inc. | 1,211,000 | 367,853 | ||||
| 2025-05-15 | 13G/A | WORX / SCWorx Corp. | 116,279 | 226,191 | ||||
| 2025-05-15 | 13G/A | PTPI / Petros Pharmaceuticals, Inc. | 2,527,084 | 5,939,954 | ||||
| 2025-05-15 | 13G/A | AYRO / StableX Technologies, Inc. | 741,513 | 946,635 | ||||
| 2025-05-14 | 13G/A | CHUC / Charlie's Holdings, Inc. | 12,078,473 | 12,078,473 | ||||
| 2025-02-26 | 13G | PTPI / Petros Pharmaceuticals, Inc. | 167,820 | 2,527,084 | ||||
| 2025-02-14 | 13G/A | AYRO / StableX Technologies, Inc. | 12,273 | 741,513 | ||||
| 2025-02-14 | 13G/A | PRSO / Peraso Inc. | 0 | 2,380,951 | ||||
| 2025-02-14 | 13G/A | XXII / 22nd Century Group, Inc. | 3,333,333 | 101,240 | ||||
| 2025-02-14 | 13G/A | CMND / Clearmind Medicine Inc. | 125,000 | 451,685 | ||||
| 2025-02-14 | 13G/A | JTAI / Jet.AI Inc. | 5,185,191 | 0 | ||||
| 2024-12-05 | 13G | WORX / SCWorx Corp. | 116,279 | |||||
| 2024-11-15 | 13G/A | SMSI / Smith Micro Software, Inc. | 1,061,812 | 0 | ||||
| 2024-11-14 | 13G/A | BDRX / Biodexa Pharmaceuticals Plc - Depositary Receipt (Common Stock) | 936,170 | 0 | ||||
| 2024-11-14 | 13G/A | 0 | ||||||
| 2024-11-14 | 13G/A | PRSO / Peraso Inc. | 120,000 | 0 | ||||
| 2024-11-14 | 13G/A | OGEN / Oragenics, Inc. | 809,090 | 0 | ||||
| 2024-11-14 | 13G/A | EDBL / Edible Garden AG Incorporated | 54,000 | 0 | ||||
| 2024-11-14 | 13G/A | AYRO / StableX Technologies, Inc. | 10,000 | 12,273 | ||||
| 2024-11-14 | 13G/A | VLCN / Volcon, Inc. | 250,000 | 0 | ||||
| 2024-11-12 | 13G/A | CHUC / Charlie's Holdings, Inc. | 12,078,473 | |||||
| 2024-10-23 | 13G | XXII / 22nd Century Group, Inc. | 3,333,333 | |||||
| 2024-10-15 | 13G | JTAI / Jet.AI Inc. | 5,185,191 | |||||
| 2024-09-11 | 13G | OGEN / Oragenics, Inc. | 809,090 | |||||
| 2024-08-08 | 13G | BDRX / Biodexa Pharmaceuticals Plc - Depositary Receipt (Common Stock) | 936,170 | 936,170 | ||||
| 2024-08-05 | 13G | BDRX / Biodexa Pharmaceuticals Plc - Depositary Receipt (Common Stock) | 936,170 | |||||
| 2024-07-16 | 13G | VLCN / Volcon, Inc. | 250,000 | |||||
| 2024-05-31 | 13G | EDBL / Edible Garden AG Incorporated | 54,000 | |||||
| 2024-02-15 | 13G | PRSO / Peraso Inc. | 120,000 | |||||
| 2024-02-14 | 13G/A | AYRO / StableX Technologies, Inc. | 10,000 | |||||
| 2024-02-14 | 13G/A | SMSI / Smith Micro Software, Inc. | 324,873 | 1,061,812 | ||||
| 2024-02-14 | 13G/A | MYMD / MyMD Pharmaceuticals, Inc. | 896,478 | 317,360 | ||||
| 2024-02-12 | 13G/A | CHUCD / Charlies Holdings Inc | 17,826,738 | 17,826,764 | ||||
| 2024-01-22 | 13G | CMND / Clearmind Medicine Inc. | 125,000 | |||||
| 2023-09-12 | 13G | AYRO / StableX Technologies, Inc. | 23,000 | 14,354,130 | ||||
| 2023-06-28 | 13G | SMSI / Smith Micro Software, Inc. | 826,070 | 324,873 | ||||
| 2023-06-16 | 13D/A | PMCB / PharmaCyte Biotech, Inc. | 1,242,615 | 189,350 | ||||
| 2023-05-12 | 13D/A | PMCB / PharmaCyte Biotech, Inc. | 1,389,869 | 1,242,615 | ||||
| 2023-02-14 | 13G/A | SVRE / SaverOne 2014 Ltd. - Depositary Receipt (Common Stock) | 681,430 | |||||
| 2023-02-14 | 13G/A | MYMD / MyMD Pharmaceuticals, Inc. | 2,178,608 | 896,478 | ||||
| 2023-02-13 | 13G/A | CHUCD / Charlies Holdings Inc | 14,851,386 | 17,826,738 | ||||
| 2022-08-15 | 13D/A | PMCB / PharmaCyte Biotech, Inc. | 1,377,469 | 1,389,869 | ||||
| 2022-07-15 | 13G | 1,218,295 | ||||||
| 2022-07-11 | 13D/A | PMCB / PharmaCyte Biotech, Inc. | 1,258,791 | 1,377,469 | ||||
| 2022-06-23 | 13D/A | PMCB / PharmaCyte Biotech, Inc. | 1,048,646 | 1,258,791 | ||||
| 2022-02-24 | 13G/A | AYRO / StableX Technologies, Inc. | 1,666,667 | 23,000 | ||||
| 2022-02-23 | 13G/A | 095428108 / Blue Earth, Inc. | 125,135 | 156,445 | ||||
| 2022-02-23 | 13G/A | MYMD / MyMD Pharmaceuticals, Inc. | 110,000 | 2,178,608 | ||||
| 2022-02-23 | 13G/A | ARTL / Artelo Biosciences, Inc. | 920,000 | 100,000 | ||||
| 2022-02-23 | 13G/A | OBLG / Oblong, Inc. | 580,000 | 1,211,000 | ||||
| 2022-02-23 | 13G/A | SYN / Synthetic Biologics Inc | 2,608,696 | 908,195 | ||||
| 2022-02-23 | 13G/A | HOTH / Hoth Therapeutics, Inc. | 1,265,822 | 1,265,822 | ||||
| 2022-02-23 | 13G/A | PTPI / Petros Pharmaceuticals, Inc. | 689,353 | 167,820 | ||||
| 2021-11-04 | 13D | PMCB / PharmaCyte Biotech, Inc. | 1,048,646 | |||||
| 2021-10-22 | 13G | PTPI / Petros Pharmaceuticals, Inc. | 689,353 | |||||
| 2021-09-21 | 13G | CHUCD / Charlies Holdings Inc | 14,851,386 | |||||
| 2021-03-18 | 13G | HOTH / Hoth Therapeutics, Inc. | 1,265,822 | |||||
| 2021-02-22 | 13G/A | 095428108 / Blue Earth, Inc. | 1,331,298 | 125,135 | ||||
| 2021-02-22 | 13G/A | MYMD / MyMD Pharmaceuticals, Inc. | 110,000 | 1,240,268 | ||||
| 2021-02-22 | 13G/A | AEMD / Aethlon Medical, Inc. | 177,167 | 149,170 | ||||
| 2021-02-22 | 13G/A | SYN / Synthetic Biologics Inc | 15,271 | 2,608,696 | ||||
| 2021-02-22 | 13G/A | VISL / Vislink Technologies, Inc. | 5,300,719 | 77,017 | ||||
| 2021-02-03 | 13G | AYRO / StableX Technologies, Inc. | 342,980 | 1,666,667 | ||||
| 2021-01-04 | 13G | 095428108 / Blue Earth, Inc. | 1,331,298 | |||||
| 2020-12-15 | 13G | OBLG / Oblong, Inc. | 580,000 | |||||
| 2020-11-19 | 13G/A | MYMD / MyMD Pharmaceuticals, Inc. | 110,000 | 1,040,540 | ||||
| 2020-10-19 | 13G | ARTL / Artelo Biosciences, Inc. | 920,000 | |||||
| 2020-02-19 | 13G | VISL / Vislink Technologies, Inc. | 1,558,758 | 5,300,719 | ||||
| 2020-02-14 | 13G/A | TNXP / Tonix Pharmaceuticals Holding Corp. | 130,634 | 100,000 | ||||
| 2020-02-14 | 13G/A | MOSY / Mosys Inc | 250,000 | |||||
| 2020-02-14 | 13G/A | GNUS / Genius Brands International Inc | 160,822 | 786,667 | ||||
| 2020-02-14 | 13G/A | TENX / Tenax Therapeutics, Inc. | 63,405 | 1,554,404 | ||||
| 2020-02-14 | 13G/A | WRAP / Wrap Technologies, Inc. | 1,888,258 | 1,337,673 | ||||
| 2020-02-14 | 13G/A | NNDM / Nano Dimension Ltd. - Depositary Receipt (Common Stock) | 9,333,000 | 933,300 | ||||
| 2020-02-14 | 13G/A | AEMD / Aethlon Medical, Inc. | 166,667 | 177,167 | ||||
| 2020-02-14 | 13G/A | 47W / Neurotrope Inc | 685,366 | 297,816 | ||||
| 2020-02-14 | 13G/A | DCAR / DropCar, Inc. | 17,732 | 549,419 | ||||
| 2020-02-14 | 13G/A | SYN / Synthetic Biologics Inc | 696,900 | 15,271 | ||||
| 2020-02-14 | 13G/A | VISL / Vislink Technologies, Inc. | 1,000,000 | 1,558,758 | ||||
| 2019-12-23 | 13G | AEMD / Aethlon Medical, Inc. | 166,667 | |||||
| 2019-12-18 | 13G | MYMD / MyMD Pharmaceuticals, Inc. | 110,000 | |||||
| 2019-07-23 | 13G | VISL / Vislink Technologies, Inc. | 1,000,000 | |||||
| 2019-05-10 | 13G | / Charlie's Holdings Inc | 482,286,556 | |||||
| 2019-02-22 | 13G/A | GNSS / Genasys Inc. | 1,453,476 | 1,592,733 | ||||
| 2019-02-14 | 13G/A | 47W / Neurotrope Inc | 674,596 | 685,366 | ||||
| 2019-02-14 | 13G/A | WRAP / Wrap Technologies, Inc. | 1,790,558 | 1,888,258 | ||||
| 2019-02-14 | 13G/A | TNXP / Tonix Pharmaceuticals Holding Corp. | 150,000 | 130,634 | ||||
| 2019-02-14 | 13G/A | GNUS / Genius Brands International Inc | 170,840 | 160,822 | ||||
| 2019-02-14 | 13G/A | NUWE / Nuwellis, Inc. | 33,732 | 1,344,000 | ||||
| 2019-02-14 | 13G/A | AYRO / StableX Technologies, Inc. | 342,980 | 17,732 | ||||
| 2019-02-14 | 13G/A | TEUM / Pareteum Corp | 3,575,573 | 0 | ||||
| 2019-02-14 | 13G/A | SEEL / Seelos Therapeutics, Inc. | 887,025 | 771,429 | ||||
| 2019-02-14 | 13G/A | GNSS / Genasys Inc. | 1,876,496 | 1,453,476 | ||||
| 2019-02-14 | 13G/A | SYN / Synthetic Biologics Inc | 720,000 | 696,900 | ||||
| 2019-02-14 | 13G/A | TENX / Tenax Therapeutics, Inc. | 777,202 | 63,405 | ||||
| 2019-02-14 | 13G/A | SMSI / Smith Micro Software, Inc. | 1,306,672 | 826,070 | ||||
| 2019-02-11 | 13G | NNDM / Nano Dimension Ltd. - Depositary Receipt (Common Stock) | 9,333,000 | |||||
| 2018-12-28 | 13G | 47W / Neurotrope Inc | 95,931 | 674,596 | ||||
| 2018-12-14 | 13G | TNXP / Tonix Pharmaceuticals Holding Corp. | 150,000 | |||||
| 2018-12-14 | 13G | TENX / Tenax Therapeutics, Inc. | 777,202 | |||||
| 2018-10-19 | 13G | WRAP / Wrap Technologies, Inc. | 1,790,558 | |||||
| 2018-10-18 | 13G | SYN / Synthetic Biologics Inc | 720,000 | 720,000 | ||||
| 2018-10-17 | 13G | SYN / Synthetic Biologics Inc | 720,000 | |||||
| 2018-10-09 | 13G | MOSY / Mosys Inc | 1,400,000 | |||||
| 2018-06-25 | 13G | GNSS / Genasys Inc. | 1,420,594 | 1,876,496 | ||||
| 2018-05-22 | 13G | SMSI / Smith Micro Software, Inc. | 1,306,672 | |||||
| 2018-04-04 | 13D | MRKR / Marker Therapeutics, Inc. | 531,393 | 509,393 | ||||
| 2018-02-14 | 13G/A | AYRO / StableX Technologies, Inc. | 342,980 | |||||
| 2018-02-14 | 13G/A | 47W / Neurotrope Inc | 717,926 | 95,931 | ||||
| 2018-02-14 | 13G/A | ATOS / Atossa Therapeutics, Inc. | 2,300,000 | 118,144 | ||||
| 2018-02-14 | 13G/A | GNUS / Genius Brands International Inc | 98,470 | 170,840 | ||||
| 2018-02-14 | 13G/A | NUWE / Nuwellis, Inc. | 515,628 | 33,732 | ||||
| 2018-02-14 | 13G/A | TPIV / TapImmune, Inc. | 592,025 | 531,393 | ||||
| 2018-02-14 | 13G/A | AYRO / StableX Technologies, Inc. | 293,650 | 342,980 | ||||
| 2018-02-14 | 13G/A | SEEL / Seelos Therapeutics, Inc. | 658,202 | 887,025 | ||||
| 2018-01-16 | 13D | RGSE / Real Goods Solar, Inc. | 352,048 | 605,000 | ||||
| 2017-12-08 | 13G | TEUM / Pareteum Corp | 3,575,573 | |||||
| 2017-11-09 | 13G | ATOS / Atossa Therapeutics, Inc. | 2,300,000 | |||||
| 2017-08-15 | 13D/A | NILE / BitNile Holdings Inc. | 417,667 | 695,152 | ||||
| 2017-06-16 | 13G | SEEL / Seelos Therapeutics, Inc. | 658,202 | |||||
| 2017-06-15 | 13D | NILE / BitNile Holdings Inc. | 417,667 | |||||
| 2017-06-14 | 13G | NUWE / Nuwellis, Inc. | 515,628 | |||||
| 2017-02-14 | 13G/A | AYRO / StableX Technologies, Inc. | 293,650 | |||||
| 2017-02-14 | 13G/A | 852383207 / The Staffing Group Ltd. | 2,718,640 | 0 | ||||
| 2017-02-14 | 13G/A | VISL / Vislink Technologies, Inc. | 7,000,000 | 249,794 | ||||
| 2017-02-14 | 13G/A | AYRO / StableX Technologies, Inc. | 278,634 | 293,650 | ||||
| 2017-02-14 | 13G/A | MGTI / MGT Capital Investments, Inc. | 1,740,496 | 0 | ||||
| 2017-02-14 | 13G/A | RGSE / Real Goods Solar, Inc. | 2,727,273 | 352,048 | ||||
| 2017-02-14 | 13G/A | GENE / Genetic Technologies Limited - Depositary Receipt (Common Stock) | 240,000,000 | 8,349,000 | ||||
| 2017-02-14 | 13G/A | GNUS / Genius Brands International Inc | 98,470 | |||||
| 2017-02-14 | 13G/A | 47W / Neurotrope Inc | 5,102,574 | 717,926 | ||||
| 2017-02-14 | 13G/A | TPIV / TapImmune, Inc. | 3,211,114 | 592,025 | ||||
| 2016-12-20 | 13G | RGSE / Real Goods Solar, Inc. | 2,727,273 | |||||
| 2016-12-14 | 13G | GENE / Genetic Technologies Limited - Depositary Receipt (Common Stock) | 0 | 240,000,000 | ||||
| 2016-09-16 | 13G | AYRO / StableX Technologies, Inc. | 287,308 | |||||
| 2016-09-16 | 13G | AYRO / StableX Technologies, Inc. | 277,839 | 287,308 | ||||
| 2016-09-08 | 13D/A | ALAN / Alanco Technologies Inc | 474,398 | |||||
| 2016-08-17 | 13D/A | AYRO / StableX Technologies, Inc. | 277,839 | |||||
| 2016-08-17 | 13D/A | AYRO / StableX Technologies, Inc. | 278,568 | 277,839 | ||||
| 2016-08-12 | 13G | 47W / Neurotrope Inc | 5,102,574 | 5,102,574 | ||||
| 2016-08-09 | 13D/A | 47W / Neurotrope Inc | 5,102,574 | 5,102,574 | ||||
| 2016-08-02 | 13D/A | AYRO / StableX Technologies, Inc. | 278,568 | |||||
| 2016-08-02 | 13D/A | AYRO / StableX Technologies, Inc. | 276,288 | 278,568 | ||||
| 2016-07-19 | 13D | AYRO / StableX Technologies, Inc. | 276,288 | |||||
| 2016-07-19 | 13D | AYRO / StableX Technologies, Inc. | 57,160 | 276,288 | ||||
| 2016-07-15 | 13D | 47W / Neurotrope Inc | 300,000 | 5,102,574 | ||||
| 2016-05-20 | 13G | VISL / Vislink Technologies, Inc. | 7,000,000 | |||||
| 2016-05-09 | 13D/A | US6363752063 / National Holdings Corp. | 845,313 | |||||
| 2016-05-09 | 13G | MGTI / MGT Capital Investments, Inc. | 1,339,096 | 1,740,496 | ||||
| 2016-03-15 | 13D/A | GNSS / Genasys Inc. | 1,851,896 | 1,420,594 | ||||
| 2016-02-08 | 13G/A | AYRO / StableX Technologies, Inc. | 57,160 | |||||
| 2016-02-08 | 13G/A | TPIV / TapImmune, Inc. | 1,945,795 | 3,211,114 | ||||
| 2016-02-08 | 13G | 47W / Neurotrope Inc | 300,000 | |||||
| 2016-02-08 | 13G/A | AYRO / StableX Technologies, Inc. | 2,229,685 | 57,160 | ||||
| 2016-02-08 | 13G/A | AIKI / AIkido Pharma Inc | 380,445 | |||||
| 2016-02-08 | 13G/A | XWEL / XWELL, Inc. | 39,268 | |||||
| 2016-02-08 | 13G/A | GENE / Genetic Technologies Limited - Depositary Receipt (Common Stock) | 166,666,650 | 0 | ||||
| 2016-02-08 | 13D/A | MGTI / MGT Capital Investments, Inc. | 1,339,096 | |||||
| 2016-01-14 | 13D/A | GNSS / Genasys Inc. | 1,883,900 | 1,851,896 | ||||
| 2015-09-04 | 13G/A | 852383207 / The Staffing Group Ltd. | 2,902,406 | |||||
| 2015-09-04 | 13G | 852383207 / The Staffing Group Ltd. | 2,718,640 | |||||
| 2015-07-17 | 13G/A | AYRO / StableX Technologies, Inc. | 2,364,975 | |||||
| 2015-07-17 | 13G/A | AYRO / StableX Technologies, Inc. | 2,364,975 | |||||
| 2015-06-22 | 13D | GNSS / Genasys Inc. | 1,883,900 | |||||
| 2015-05-12 | 13G | XWEL / XWELL, Inc. | ||||||
| 2015-03-16 | 13G | GENE / Genetic Technologies Limited - Depositary Receipt (Common Stock) | 166,666,650 | |||||
| 2015-03-13 | 13G | TPIV / TapImmune, Inc. | 1,945,795 | |||||
| 2015-02-17 | 13G/A | AIKI / AIkido Pharma Inc | 0 | |||||
| 2015-02-17 | 13G/A | AYRO / StableX Technologies, Inc. | 14,303 | |||||
| 2015-02-17 | 13G/A | GNSS / Genasys Inc. | 1,773,795 | |||||
| 2014-10-02 | 13D/A | MGTI / MGT Capital Investments, Inc. | 1,039,096 | |||||
| 2014-07-01 | 13D/A | MGTI / MGT Capital Investments, Inc. | 929,915 | |||||
| 2014-06-26 | 13D/A | US6363752063 / National Holdings Corp. | 8,453,123 | |||||
| 2014-06-09 | 13D/A | US6363752063 / National Holdings Corp. | 7,453,123 | |||||
| 2014-06-09 | 13D/A | MGTI / MGT Capital Investments, Inc. | 929,915 | |||||
| 2014-06-03 | 13G | AIKI / AIkido Pharma Inc | 375,000 | |||||
| 2014-05-19 | 13D | ALAN / Alanco Technologies Inc | 474,398 | |||||
| 2014-02-12 | 13G/A | AYRO / StableX Technologies, Inc. | 89,303 | |||||
| 2014-02-12 | 13G/A | NBY / Stablecoin Development Corporation | 1,185,396 | |||||
| 2014-02-12 | 13G/A | AIKI / AIkido Pharma Inc | 167,274 | |||||
| 2014-02-12 | 13G | GNSS / Genasys Inc. | 2,617,626 | |||||
| 2014-02-11 | 13D/A | US6363752063 / National Holdings Corp. | 7,288,623 | |||||
| 2014-02-05 | 13D/A | MGTI / MGT Capital Investments, Inc. | 900,543 | |||||
| 2013-12-16 | 13D | MGTI / MGT Capital Investments, Inc. | 765,873 | |||||
| 2013-11-21 | 13D | US6363752063 / National Holdings Corp. | 7,276,625 | |||||
| 2013-09-23 | 13G | US6363752063 / National Holdings Corp. | 6,364,203 | |||||
| 2013-06-13 | 13D/A | GNSS / Genasys Inc. | 3,015,765 | |||||
| 2013-05-24 | 13D/A | GNSS / Genasys Inc. | 2,291,969 | |||||
| 2013-05-14 | 13D | TWFH / 24Holdings, Inc. | ||||||
| 2013-03-04 | 13D/A | GNSS / Genasys Inc. | 2,174,192 | |||||
| 2013-02-14 | 13G | AIKI / AIkido Pharma Inc | 46,990 | |||||
| 2013-02-12 | 13G/A | XWEL / XWELL, Inc. | 2,111,559 | |||||
| 2013-02-12 | 13G | AYRO / StableX Technologies, Inc. | 761,164 | |||||
| 2013-02-12 | 13G | MGTI / MGT Capital Investments, Inc. | 2,574 | |||||
| 2013-02-12 | 13G | NBY / Stablecoin Development Corporation | 2,842,500 | |||||
| 2013-02-12 | 13G | VALV / Shengkai Innovations, Inc. | 1,908,570 | |||||
| 2013-02-12 | 13G/A | ALTO / Alto Ingredients, Inc. | 7,712,169 | |||||
| 2013-01-17 | 13D | GNSS / Genasys Inc. | 1,929,711 | |||||
| 2012-10-09 | 13G | ALTO / Alto Ingredients, Inc. | 12,500,000 | |||||
| 2012-02-14 | 13G/A | JVA / Coffee Holding Co., Inc. | 0 | |||||
| 2012-02-14 | 13G/A | XWEL / XWELL, Inc. | 884,803 | |||||
| 2012-02-14 | 13G/A | 10,458,877 | ||||||
| 2012-02-14 | 13G/A | ABIO / ARCA biopharma, Inc. | 605,643 |